Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1966 Feb 28;123(3):469–486. doi: 10.1084/jem.123.3.469

MICROBIAL PERSISTENCE

II. CHARACTERISTICS OF THE STERILE STATE OF TUBERCLE BACILLI

Robert M McCune 1, Floyd M Feldmann 1, Walsh McDermott 1
PMCID: PMC2138156  PMID: 4957011

Abstract

The capability of tubercle bacilli to assume a long continued sterile state in the tissues when exposed to pyrazinamide and isoniazid is a highly specific drug-microbe phenomenon in which host participation is not critical. Although it is the pyrazinamide that possesses the sterilizing type of action, the role of the isoniazid is specific and essential. The isoniazid serves to convert a phenomenon that occurs irregularly with pyrazinamide alone into one that occurs with a high degree of uniformity. The observations suggest a competition between isoniazid and the pyrazinamide (or its parent nicotinamide) for a site or entrance in or on the tubercle bacilli and for sterilization, the isoniazid apparently must reach the site first. The rare failures to attain complete sterilization, appear to depend on the emergence of pyrazinamide-resistance which prevents the necessary dependent action of the two drugs. Populations already in the sterile state are nevertheless subject to a continued drug influence. Whether this represents a direct action on the sterile bacilli or an indirect effect produced by making the environment hostile to microbial revival, cannot be determined from the present observations.

Full Text

The Full Text of this article is available as a PDF (1.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CANETTI G., RIST N., GROSSET J. PRIMARY DRUG RESISTANCE IN TUBERCULOSIS. Am Rev Respir Dis. 1964 Nov;90:792–799. doi: 10.1164/arrd.1964.90.5.792. [DOI] [PubMed] [Google Scholar]
  2. GRUMBACH F. Activité antituberculeuse expérimentale du pyrazinamide (P.Z.A.). Ann Inst Pasteur (Paris) 1958 Jun;94(6):694–708. [PubMed] [Google Scholar]
  3. GRUMBACH F., CANETTI G., GROSSET J. FURTHER EXPERIMENTS ON LONG-TERM CHEMOTHERAPY OF ADVANCED MURINE TUBERCULOSIS, WITH EMPHASIS ON INTERMITTENT REGIMES. Tubercle. 1964 Jun;45:125–135. doi: 10.1016/s0041-3879(64)80070-2. [DOI] [PubMed] [Google Scholar]
  4. LAMBERT H. P. The influence of chemoprophylaxis on immunity in experimental tuberculosis. Am Rev Respir Dis. 1960 Nov;82:619–626. doi: 10.1164/arrd.1960.82.5.619. [DOI] [PubMed] [Google Scholar]
  5. LEE S. H., MCCUNE R. M., Jr, MCDERMOTT W., TOMPSETT R., WASZ-HOCKERT O. Resistance of tubercle bacilli to pyrazinamide in vivo. Am Rev Tuberc. 1956 Oct;74(4):572–580. doi: 10.1164/artpd.1956.74.4.572. [DOI] [PubMed] [Google Scholar]
  6. MCCUNE R. M., Jr, MCDERMOTT W., TOMPSETT R. The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug. J Exp Med. 1956 Nov 1;104(5):763–802. doi: 10.1084/jem.104.5.763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. MCCUNE R. M., Jr, TOMPSETT R. Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy. J Exp Med. 1956 Nov 1;104(5):737–762. doi: 10.1084/jem.104.5.737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. McCUNE R., LEE S. H., DEUSCHLE K., McDERMOTT W. Ineffectiveness of isoniazid in modifying the phenomenon of microbial persistence. Am Rev Tuberc. 1957 Dec;76(6):1106–1109. doi: 10.1164/artpd.1957.76.6.1106. [DOI] [PubMed] [Google Scholar]
  9. McCune R. M., Feldmann F. M., Lambert H. P., McDermott W. Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues. J Exp Med. 1966 Mar 1;123(3):445–468. doi: 10.1084/jem.123.3.445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. McDERMOTT W. Inapparent infection: relation of latent and dormant infections to microbial persistence. Public Health Rep. 1959 Jun;74(6):485–499. [PMC free article] [PubMed] [Google Scholar]
  11. McDERMOTT W. Microbial persistence. Yale J Biol Med. 1958 Feb;30(4):257–291. [PMC free article] [PubMed] [Google Scholar]
  12. PIERCE-CHASE C. H., FAUVE R. M., DUBOS R. CORYNEBACTERIAL PSEUDOTUBERCULOSIS IN MICE. I. COMPARATIVE SUSCEPTIBILITY OF MOUSE STRAINS TO EXPERIMENTAL INFECTION WITH CORYNEBACTERIUM KUTSCHERI. J Exp Med. 1964 Aug 1;120:267–281. doi: 10.1084/jem.120.2.267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. REIMANN H. A., MA P. P. DISSOCIANTS OF M. TUBERCULOSIS AND ATYPICAL MYCOBACTERIA. Am Rev Respir Dis. 1965 Aug;92:193–209. doi: 10.1164/arrd.1965.92.2.193. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES